Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Acarbose & Type 2 Diabetes (T2D), the FDA has approved acarbose as an addition to diet and exercise for adults with type 2 diabetes. It works by delaying carbohydrate digestion and delays absorption in the gut. This reduces postprandial glucose excursions (1)
Acarbose is listed among nationally authorised medicinal products reported to the EMA. The European Summary of Product Characteristics (SmPC) for acarbose 50 mg tablets states it is indicated for the treatment of Type 2 Diabetes (T2D) in patients inadequately controlled on diet alone or on diet plus other oral hypo…